Cardiotoxicity associated with tyrosine kinase-targeted anticancer therapy

被引：0
作者：
Wang-Soo Lee
Jaetaek Kim
机构：
[1] Chung-Ang University,Division of Cardiology, Department of Internal Medicine, College of Medicine
[2] Chung-Ang University,Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine
来源：
Molecular & Cellular Toxicology | 2018年 / 14卷
关键词：
Neoplasm; Drug therapy; Cardiotoxicity; Heart failure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：247 / 254
页数：7
相关论文
共 50 条
  • [21] Unveiling the Cardiotoxicity Conundrum: Navigating the Seas of Tyrosine Kinase Inhibitor Therapies
    Ekram, Jahanzaib
    Rathore, Azeem
    Avila, Carlos
    Hussein, Rahbia
    Alomar, Mohammed
    CANCER CONTROL, 2024, 31
  • [22] Cardiotoxicity of Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients
    Berisha, Adriatik
    Placci, Angelo
    Piccaluga, Pier Paolo
    HEMATO, 2023, 4 (01): : 68 - 75
  • [23] Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management
    Vallerio, P.
    Orenti, A.
    Tosi, F.
    Maistrello, M.
    Palazzini, M.
    Cingarlini, S.
    Colombo, P.
    Bertuzzi, M.
    Spina, F.
    Amatu, A.
    Lombardo, R.
    Prata, I
    Scaglione, F.
    Vighi, G. D.
    Severgnini, B.
    Siena, S.
    Giannattasio, C.
    Boracchi, P.
    Sartore-Bianchi, A.
    ESMO OPEN, 2022, 7 (01)
  • [24] Pluripotent Stem Cell Modeling of Anticancer Therapy–Induced Cardiotoxicity
    Davi M. Lyra-Leite
    Paul W. Burridge
    Current Cardiology Reports, 2020, 22
  • [25] The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity
    Suleiman, Muna
    Al Najjar, Afnan
    Zakaria, Zain Z.
    Ahmed, Rashid
    Yalcin, Huseyin C.
    Korashy, Hesham M.
    Uddin, Shahab
    Riaz, Sadaf
    Abdulrahman, Nabeel
    Mraiche, Fatima
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2024, 17 (02) : 334 - 344
  • [26] Subclinical Cardiotoxicity Associated With Cancer Therapy
    Yeh, Edward T. H.
    Vejpongsa, Pimprapa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (23) : 2523 - 2525
  • [27] Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
    Yu, Anthony F.
    Moskowitz, Chaya S.
    Chuy, Katherine Lee
    Yang, Ji
    Dang, Chau T.
    Liu, Jennifer E.
    Oeffinger, Kevin C.
    Steingart, Richard M.
    JACC: CARDIOONCOLOGY, 2020, 2 (02): : 166 - 175
  • [28] Systems pharmacological analysis of mitochondrial cardiotoxicity induced by selected tyrosine kinase inhibitors
    Vaidya, Tanaya
    Kamta, Jeff
    Chaar, Maher
    Ande, Anusha
    Ait-Oudhia, Sihem
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 (03) : 401 - 418
  • [29] Systems pharmacological analysis of mitochondrial cardiotoxicity induced by selected tyrosine kinase inhibitors
    Tanaya Vaidya
    Jeff Kamta
    Maher Chaar
    Anusha Ande
    Sihem Ait-Oudhia
    Journal of Pharmacokinetics and Pharmacodynamics, 2018, 45 : 401 - 418
  • [30] Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors
    Shim, Jaehee V.
    Xiong, Yuguang
    Dhanan, Priyanka
    Dariolli, Rafael
    Azeloglu, Evren U.
    Hu, Bin
    Jayaraman, Gomathi
    Schaniel, Christoph
    Birtwistle, Marc R.
    Iyengar, Ravi
    Dubois, Nicole C.
    Sobie, Eric A.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345